Vital Images 3D Viewer Receives FDA Clearance

Article

Vital Images Inc. announced the FDA has granted 510(k) clearance for 3D viewing through the VitreaView universal viewer.

Vital Images Inc., a Toshiba Medical Systems Group company, has received FDA 510(k) clearance for 3D viewing through the VitreaView universal viewer, the company announced.

The advanced visualization and analysis company introduced VitreaView in June 2011. The viewer is used as a communication tool for DICOM and non-DICOM medical images through a standardized viewer, so clinicians can access the images through various systems.

“Now with 3D and tablet capabilities available via VitreaView, our customers, particularly referring physicians and clinicians, have more functionality and easier access to the tools they need,” Erkan Akyuz, president and CEO of Vital Images, said in a statement. “Also, with access to images through the EMR as part of the Stage 2 Meaningful Use criteria, VitreaView integrated with a certified EMR enables the ability to meet this objective, with a toolset and infrastructure that also meets the needs of clinical users and IT administrators.”

 

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.